Seres Therapeutics Inc - MCRB - stock price prediction, stock price target, analyst ratings from 1 analyst

Seres Therapeutics Inc has a share price target of US$ 22 and profit growth estimate of -1379.5% for Unknown Year, based on top 1 analyst call.